The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict Masimo's revenues will grow 12.8% and EPS will grow 3.7%.
The average estimate for revenue is $134.5 million. On the bottom line, the average EPS estimate is $0.28.
Last quarter, Masimo logged revenue of $132.2 million. GAAP reported sales were 18% higher than the prior-year quarter's $112.3 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
Last quarter, non-GAAP EPS came in at $0.29. GAAP EPS of $0.26 for Q4 were 13% higher than the prior-year quarter's $0.23 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the preceding quarter, gross margin was 66.0%, 50 basis points better than the prior-year quarter. Operating margin was 16.9%, 100 basis points worse than the prior-year quarter. Net margin was 11.4%, 90 basis points worse than the prior-year quarter.
The full year's average estimate for revenue is $548.6 million. The average EPS estimate is $1.15.
The stock has a five-star rating (out of five) at Motley Fool CAPS, with 169 members out of 178 rating the stock outperform, and nine members rating it underperform. Among 36 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 35 give Masimo a green thumbs-up, and one give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Masimo is hold, with an average price target of $24.69.
Is Masimo the best health care stock for you? Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks," including one above-average health care logistics company. Click here for instant access to this free report.
- Add Masimo to My Watchlist.